A decrease in circulating hsa-miR-146a-5p may play an important role in the onset and development of T2D complications through the overexpression of NF-kB and modulation of systemic inflammatory responses that cause glucose control dysfunction [36,37]. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.